A Study Evaluating Participants With Moderately to Severely Active Crohn's Disease
Status:
Recruiting
Trial end date:
2022-05-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of JNJ-active as measured by the change
in the Crohn's Disease Activity Index (CDAI) score and Simplified Endoscopic Score for
Crohn's disease (SES-CD) from baseline at Week 12.